Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer-Reference-Cited by-同舟云学术

Beneficiaries of radical surgery among clinical complete responders to neoadjuvant chemoradiotherapy in rectal cancer

Published:2021-07-21 Issue:9 Volume:112 Page:3607-3615
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Zhang Shu¹²,Zhang Rong³^ORCID,Li Rong‐zhen¹,Wang Qiao‐xuan¹,Chang Hui¹,Ding Pei‐rong⁴,Li Li‐ren³,Wu Xiao‐jun⁴,Chen Gong⁴,Zeng Zhi‐fan⁴,Xiao Wei‐wei¹^ORCID,Gao Yuan‐hong¹^ORCID

Affiliation:

1. Department of Radiation Oncology Sun Yat‐sen University Cancer Centre State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangzhou China

2. Department of Radiation Oncology The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou China

3. Department of Endoscopy Sun Yat‐sen University Cancer Centre State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangzhou China

4. Department of Colorectal Surgery Sun Yat‐sen University Cancer Centre State Key Laboratory of Oncology in South China Collaborative Innovation Centre for Cancer Medicine Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15039

Reference48 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer incidence and mortality: A cohort study in China, 2008–2013

3. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

4. Low Anterior Resection Syndrome and Quality of Life After Sphincter-Sparing Rectal Cancer Surgery: A Long-term Longitudinal Follow-up

5. Urinary and sexual dysfunction after rectal cancer treatment

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial;Cancer Cell;2024-09

2. Total neoadjuvant treatment to increase the clinical complete response rate for distal locally advanced rectal cancer (TESS): A study protocol of a prospective, open‐label, multicenter, single‐arm, phase 2 trial;Cancer Medicine;2023-05-08

3. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy;World Journal of Gastrointestinal Oncology;2022-10-15